C
ISSUER//CIK 0000895051
CASI Pharmaceuticals, Inc (DE)
Exchange
—
Entity type
operating
Fiscal year end
Dec 31
Headquarters
DE
Recent Filings
- SC 13D/A274.8 KBCASI Pharmaceuticals, Inc (DE)Feb 20, 11:40 AM ET·0000950103-24-002384
- 8-K206.0 KBCASI Pharmaceuticals, Inc (DE)Mar 21, 4:41 PM ET·0001104659-23-035108
- SC 13D/A87.9 KBCASI Pharmaceuticals, Inc.Feb 21, 7:33 AM ET·0000950103-23-002616
- SC 13G/A285.2 KBCASI Pharmaceuticals, Inc.Feb 9, 10:48 AM ET·0001623632-23-000271
- SC 13G/A212.4 KBCASI Pharmaceuticals, Inc.Feb 1, 10:39 AM ET·0001623632-23-000216
- 8-K328.3 KBCASI Pharmaceuticals, Inc.Jan 31, 4:01 PM ET·0001104659-23-008576
- 8-K363.7 KBCASI Pharmaceuticals, Inc.Nov 14, 4:00 PM ET·0001104659-22-118471
- 10-Q7.6 MBCASI Pharmaceuticals, Inc.Nov 14, 9:02 AM ET·0001558370-22-017615
- 8-K224.4 KBCASI Pharmaceuticals, Inc.Sep 23, 4:02 PM ET·0001104659-22-102663
- 8-K357.4 KBCASI Pharmaceuticals, Inc.Aug 12, 4:01 PM ET·0001104659-22-090027
Insiders
10Tickers
No tickers on record
Addresses
business
9620 MEDICAL CENTER DR STE 300
ROCKVILLE, MD, 20850
mailing
9620 MEDICAL CENTER DR STE 300
ROCKVILLE, MD, 20850
Former Names
- CASI Pharmaceuticals, Inc.2023-02-21
- ENTREMED INC2014-06-13